Meropenem in neonatal severe infections due to multiresistant gram-negative bacteria (Q32120470)

6 July 2017

Meropenem in neonatal severe infections due to multiresistant gram-negative bacteria (English)

1 reference

6 July 2017

multiple drug resistance

0 references

Gram-negative bacteria

0 references

1 reference

Köksal N

1

1 reference

6 July 2017

Hacimustafaoğlu M

series ordinal

2

1 reference

6 July 2017

Bağci S

series ordinal

3

1 reference

6 July 2017

Celebi S

series ordinal

4

1 reference

6 July 2017

1 January 2001

1 reference

Indian Journal of Pediatrics

6 July 2017

1 reference

6 July 2017

68

1 reference

6 July 2017

1

1 reference

6 July 2017

15-19

1 reference

Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.

6 July 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

Safety evaluation of meropenem in animals: studies on the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

The pharmacokinetics of meropenem in infants and children: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02728850

Challenges in the management of serious infections in pediatric patients

21 January 2018

1 reference

12 December 2020

Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients

1 reference

12 December 2020

Unique epidemiology of nosocomial infection in a children's hospital

1 reference

12 December 2020

Meropenem: a new, extremely broad spectrum beta-lactam antibiotic for serious infections in pediatrics

1 reference

12 December 2020

The outcome of neonatal septicemia during fifteen years

1 reference

12 December 2020

Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System

1 reference

12 December 2020

An outbreak of antibiotic multiresistant Klebsiella at the Neonatal Intensive Care Unit, Kaplan Hospital, Rehovot, Israel, November 1991 to April 1992

1 reference

12 December 2020

[Use of meropenem in the treatment of severe infections in newborns]

1 reference

12 December 2020

Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group

1 reference

12 December 2020

Low birth weight and nosocomial infection of neonates in a neonatal intensive care unit

1 reference

12 December 2020

Nosocomial infections in a newborn intensive-care unit. Results of forty-one months of surveillance

1 reference

12 December 2020

Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group

1 reference

12 December 2020

Meropenem: evaluation of a new generation carbapenem

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02728850

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference